Evolus Historical Balance Sheet

EOLS Stock

USD 13.03 0.22 1.66%

Trend analysis of Evolus Inc balance sheet accounts such as Other Current Liabilities of 31.4 M or Total Current Liabilities of 60 M provides information on Evolus' total assets, liabilities, and equity, which is the actual value of Evolus Inc to its prevalent stockholders. By breaking down trends over time using Evolus balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Evolus Inc latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Evolus Inc is a good buy for the upcoming year.

Evolus Inventory

9.81 Million

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Evolus Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

About Evolus Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Evolus Inc at a specified time, usually calculated after every quarter, six months, or one year. Evolus Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Evolus and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Evolus currently owns. An asset can also be divided into two categories, current and non-current.

Evolus Balance Sheet Chart

At this time, Evolus' Total Stockholder Equity is comparatively stable compared to the past year. Other Liabilities is likely to gain to about 46.9 M in 2025, whereas Short and Long Term Debt Total is likely to drop slightly above 8 M in 2025.

Total Assets Short Long Term Debt Total Other Current Liab Total Current Liabilities

Add Fundamental

Total Assets

Total assets refers to the total amount of Evolus assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Evolus Inc books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Evolus balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Evolus Inc are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Most accounts from Evolus' balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Evolus Inc current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Evolus Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

	2022	2023	2024	2025 (projected)
Short and Long Term Debt Total	73.2M	126.5M	8.5M	8.0M
Total Assets	178.0M	189.0M	232.6M	196.8M

Short Long Term Debt Total Total Assets

Evolus balance sheet Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Good Will	Common Stock Shares Outstanding	Short Term Investments	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Deferred Long Term Liab	Short Long Term Debt	Total Current Assets	Short Term Debt	Intangible Assets	Non Currrent Assets Other	Capital Surpluse
Total Assets		0.2	0.72	0.13	-0.65	0.73	0.29	-0.51	-0.79	0.81	0.93	0.59	-0.32	0.77	0.67	0.89	0.59	0.64	0.79	-0.94	0.56	1.0	-0.32	-0.46	-0.92	0.88
Short Long Term Debt Total	0.2		0.2	0.77	-0.38	-0.13	-0.54	0.72	0.02	0.08	0.01	0.01	0.41	0.03	-0.14	0.02	0.11	-0.03	0.55	-0.31	0.63	0.21	0.68	0.19	-0.34	0.17
Other Current Liab	0.72	0.2		0.37	-0.64	0.51	-0.16	-0.36	-0.74	0.88	0.72	0.34	-0.24	0.66	0.49	0.69	0.75	0.71	0.81	-0.65	0.25	0.73	-0.21	-0.44	-0.64	0.66
Total Current Liabilities	0.13	0.77	0.37		-0.31	-0.2	-0.85	0.59	-0.03	0.16	-0.07	0.09	0.03	-0.01	-0.12	-0.13	0.08	0.01	0.63	-0.23	0.65	0.13	0.82	0.06	-0.26	0.09
Total Stockholder Equity	-0.65	-0.38	-0.64	-0.31		-0.53	-0.12	0.25	0.22	-0.46	-0.76	-0.3	-0.2	-0.2	-0.05	-0.38	-0.73	-0.19	-0.51	0.52	-0.26	-0.65	0.02	-0.11	0.51	-0.35
Other Liab	0.73	-0.13	0.51	-0.2	-0.53		0.46	-0.68	-0.48	0.57	0.84	0.44	-0.2	0.41	0.31	0.7	0.31	0.27	0.4	-0.74	0.21	0.72	-0.51	-0.19	-0.72	0.56
Net Tangible Assets	0.29	-0.54	-0.16	-0.85	-0.12	0.46		-0.71	-0.14	0.04	0.47	0.09	-0.01	0.21	0.29	0.38	0.2	0.13	-0.33	-0.16	-0.31	0.3	-0.79	-0.1	-0.12	0.22
Net Debt	-0.51	0.72	-0.36	0.59	0.25	-0.68	-0.71		0.5	-0.47	-0.69	-0.37	0.49	-0.43	-0.51	-0.57	-0.39	-0.42	-0.04	0.36	0.23	-0.5	0.84	0.4	0.32	-0.41
Retained Earnings	-0.79	0.02	-0.74	-0.03	0.22	-0.48	-0.14	0.5		-0.84	-0.68	-0.4	0.57	-0.95	-0.92	-0.89	-0.55	-0.92	-0.74	0.77	-0.36	-0.79	0.47	0.86	0.76	-0.91
Accounts Payable	0.81	0.08	0.88	0.16	-0.46	0.57	0.04	-0.47	-0.84		0.74	0.45	-0.33	0.8	0.65	0.83	0.55	0.77	0.76	-0.74	0.31	0.81	-0.38	-0.51	-0.73	0.8
Cash	0.93	0.01	0.72	-0.07	-0.76	0.84	0.47	-0.69	-0.68	0.74		0.51	-0.22	0.64	0.55	0.83	0.69	0.56	0.6	-0.82	0.29	0.93	-0.51	-0.35	-0.8	0.75
Non Current Assets Total	0.59	0.01	0.34	0.09	-0.3	0.44	0.09	-0.37	-0.4	0.45	0.51		-0.61	0.2	0.27	0.46	0.17	0.06	0.46	-0.51	0.36	0.55	-0.16	-0.2	-0.5	0.3
Good Will	-0.32	0.41	-0.24	0.03	-0.2	-0.2	-0.01	0.49	0.57	-0.33	-0.22	-0.61		-0.37	-0.61	-0.34	-0.04	-0.35	-0.31	0.32	-0.24	-0.3	0.26	0.71	0.32	-0.34
Common Stock Shares Outstanding	0.77	0.03	0.66	-0.01	-0.2	0.41	0.21	-0.43	-0.95	0.8	0.64	0.2	-0.37		0.92	0.88	0.52	0.96	0.68	-0.75	0.37	0.78	-0.45	-0.79	-0.73	0.95
Short Term Investments	0.67	-0.14	0.49	-0.12	-0.05	0.31	0.29	-0.51	-0.92	0.65	0.55	0.27	-0.61	0.92		0.77	0.45	0.89	0.54	-0.66	0.35	0.68	-0.48	-0.93	-0.65	0.87
Non Current Liabilities Total	0.89	0.02	0.69	-0.13	-0.38	0.7	0.38	-0.57	-0.89	0.83	0.83	0.46	-0.34	0.88	0.77		0.53	0.78	0.69	-0.83	0.31	0.89	-0.58	-0.59	-0.81	0.9
Other Current Assets	0.59	0.11	0.75	0.08	-0.73	0.31	0.2	-0.39	-0.55	0.55	0.69	0.17	-0.04	0.52	0.45	0.53		0.61	0.47	-0.41	-0.03	0.6	-0.36	-0.37	-0.39	0.48
Other Stockholder Equity	0.64	-0.03	0.71	0.01	-0.19	0.27	0.13	-0.42	-0.92	0.77	0.56	0.06	-0.35	0.96	0.89	0.78	0.61		0.62	-0.59	0.2	0.66	-0.44	-0.81	-0.57	0.85
Total Liab	0.79	0.55	0.81	0.63	-0.51	0.4	-0.33	-0.04	-0.74	0.76	0.6	0.46	-0.31	0.68	0.54	0.69	0.47	0.62		-0.83	0.73	0.79	0.14	-0.46	-0.84	0.77
Deferred Long Term Liab	-0.94	-0.31	-0.65	-0.23	0.52	-0.74	-0.16	0.36	0.77	-0.74	-0.82	-0.51	0.32	-0.75	-0.66	-0.83	-0.41	-0.59	-0.83		-0.72	-0.94	0.19	0.51	1.0	-0.9
Short Long Term Debt	0.56	0.63	0.25	0.65	-0.26	0.21	-0.31	0.23	-0.36	0.31	0.29	0.36	-0.24	0.37	0.35	0.31	-0.03	0.2	0.73	-0.72		0.56	0.49	-0.27	-0.74	0.57
Total Current Assets	1.0	0.21	0.73	0.13	-0.65	0.72	0.3	-0.5	-0.79	0.81	0.93	0.55	-0.3	0.78	0.68	0.89	0.6	0.66	0.79	-0.94	0.56		-0.32	-0.46	-0.93	0.9
Short Term Debt	-0.32	0.68	-0.21	0.82	0.02	-0.51	-0.79	0.84	0.47	-0.38	-0.51	-0.16	0.26	-0.45	-0.48	-0.58	-0.36	-0.44	0.14	0.19	0.49	-0.32		0.4	0.14	-0.33
Intangible Assets	-0.46	0.19	-0.44	0.06	-0.11	-0.19	-0.1	0.4	0.86	-0.51	-0.35	-0.2	0.71	-0.79	-0.93	-0.59	-0.37	-0.81	-0.46	0.51	-0.27	-0.46	0.4		0.5	-0.7
Non Currrent Assets Other	-0.92	-0.34	-0.64	-0.26	0.51	-0.72	-0.12	0.32	0.76	-0.73	-0.8	-0.5	0.32	-0.73	-0.65	-0.81	-0.39	-0.57	-0.84	1.0	-0.74	-0.93	0.14	0.5		-0.89
Capital Surpluse	0.88	0.17	0.66	0.09	-0.35	0.56	0.22	-0.41	-0.91	0.8	0.75	0.3	-0.34	0.95	0.87	0.9	0.48	0.85	0.77	-0.9	0.57	0.9	-0.33	-0.7	-0.89

Click cells to compare fundamentals

Evolus Account Relationship Matchups

Evolus balance sheet Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	209.1M	257.5M	178.0M	189.0M	232.6M	196.8M
Short Long Term Debt Total	138.3M	74.7M	73.2M	126.5M	8.5M	8.0M
Other Current Liab	95.0M	49.0M	34.9M	31.6M	50.3M	31.4M
Total Current Liabilities	180.2M	57.7M	46.5M	48.3M	63.0M	60.0M
Total Stockholder Equity	(376.1M)	(422.9M)	18.5M	(20.7M)	5.5M	5.8M
Other Liab	59.1M	58.1M	44.5M	39.9M	45.9M	46.9M
Net Tangible Assets	(1.4M)	(149.5M)	10.0M	(51.3M)	(59.0M)	(62.0M)
Net Debt	35.8M	(71.5M)	19.3M	63.7M	(78.5M)	(74.6M)
Retained Earnings	(376.1M)	(422.9M)	(497.3M)	(559.0M)	(609.4M)	(578.9M)
Accounts Payable	9.6M	6.1M	8.9M	4.3M	9.2M	5.4M
Cash	102.6M	146.3M	53.9M	62.8M	87.0M	72.6M
Non Current Assets Total	81.5M	78.7M	77.2M	76.6M	81.2M	87.4M
Common Stock Shares Outstanding	33.7M	49.8M	56.1M	56.9M	62.0M	40.9M
Liabilities And Stockholders Equity	(94.0M)	(247.3M)	178.0M	189.0M	232.6M	244.2M
Non Current Liabilities Total	101.8M	117.9M	113.0M	161.4M	164.1M	102.8M
Other Current Assets	11.8M	16.1M	5.6M	8.1M	4.6M	6.3M
Other Stockholder Equity	303.1M	504.8M	516.1M	538.7M	615.8M	317.4M
Total Liab	282.0M	175.6M	159.5M	209.7M	227.0M	185.2M
Total Current Assets	127.6M	178.8M	100.8M	112.4M	151.3M	109.4M
Short Term Debt	75.6M	2.5M	2.6M	1.4M	3.4M	3.3M
Intangible Assets	55.3M	50.6M	48.6M	47.1M	48.8M	42.7M
Non Currrent Assets Other	240K	2.8M	2.8M	409K	858K	815.1K
Other Assets	3.7M	32.5M	2.8M	1.0	1.15	1.09
Net Receivables	9.7M	14.7M	22.4M	30.5M	47.7M	50.1M
Net Invested Capital	61M	153.1M	90.4M	99.7M	127.0M	93.9M
Net Working Capital	(52.6M)	121.1M	54.3M	64.1M	88.4M	48.4M
Long Term Debt	40.5M	71.2M	71.9M	120.4M	121.5M	83.9M
Cash And Short Term Investments	107.6M	146.3M	53.9M	62.8M	87.0M	77.8M
Property Plant And Equipment Net	4.7M	4.1M	4.6M	7.9M	10.4M	6.7M
Capital Lease Obligations	4.4M	3.5M	2.5M	6.2M	8.5M	5.5M
Inventory	3.4M	1.8M	18.9M	11.0M	12.2M	9.8M
Property Plant And Equipment Gross	4.7M	4.1M	4.6M	7.9M	13.9M	7.4M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Evolus Stock Analysis

When running Evolus' price analysis, check to measure Evolus' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Evolus is operating at the current time. Most of Evolus' value examination focuses on studying past and present price action to predict the probability of Evolus' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Evolus' price. Additionally, you may evaluate how the addition of Evolus to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Evolus Historical Balance Sheet

Evolus Inventory

9.81 Million

About Evolus Balance Sheet Analysis

Evolus Balance Sheet Chart

Total Assets

Total Current Liabilities

Evolus balance sheet Correlations

Evolus Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Evolus balance sheet Accounts

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for Evolus Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Current Assets	+ 1.0	Total Assets
Non Currrent Assets Other	+ 1.0	Deferred Long Term Liab
Other Stockholder Equity	+ 0.96	Common Stock Shares Outstanding
Capital Surpluse	+ 0.95	Common Stock Shares Outstanding
Cash	+ 0.93	Total Assets
Total Current Assets	+ 0.93	Cash

Common Stock Shares Outstanding	- 0.95	Retained Earnings
Total Current Assets	- 0.94	Deferred Long Term Liab
Deferred Long Term Liab	- 0.94	Total Assets
Non Currrent Assets Other	- 0.93	Total Current Assets
Intangible Assets	- 0.93	Short Term Investments
Other Stockholder Equity	- 0.92	Retained Earnings